Sophie Sun, MBAManaging Director, Merck China Innovation Hub; VP, Merck Strategy and Transformation China at Merck
Sophie Sun is currently Managing Director of Merck China Innovation Hub and Vice President of Merck Strategy and Transformation China. In this role, she leads the corporate efforts of driving strategic planning and initiatives of innovation and digitalization for Merck in China. Sophie is a member of the global leadership team of Group Strategy & Transformation, and Chair of China Innovation Committee for Merck. She is also the Chair of China Digital Council for Merck.
Sophie joined Merck in 2009, and took different roles with increased responsibilities in the field of communications, sales, marketing, strategy and business development. Sophie worked in both strategic markets including China and US, and global function of GBF Oncology. She was a member of the China Senior Leadership Team of Merck Biopharma China before moving to the US in 2013, where she worked on the global launch of Merck’s first immuno-oncology drug, as Director Global Commercial Oncology among other roles.
Before joining Merck, Sophie worked as a consultant for over eight years in China and France, and served a broad portfolio of clients from different industries, including healthcare, technology, chemicals and finance with international marketing and communications groups, including IPG and WPP.
Sophie holds a MBA degree from MIT Sloan School of Management and a MA degree from Renmin University of China. Sophie translated and published two books in the psychology management area. She is a member of MIT Alumni Club of Shanghai, and a member of Bayhelix Group. She is committed to driving china's business transformation through innovation, actively exploring China's innovation ecosystem and expanding global new technologies and product pipeline. She is an active speaker on innovation, digitalization and female leadership, and mentor and jury member for several startup incubators, accelerators and other organizations or programs.